Wounding promotes ovarian cancer progression and decreases efficacy of cisplatin in a syngeneic mouse model
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Wounding promotes ovarian cancer progression and decreases efficacy of cisplatin in a syngeneic mouse model
Authors
Keywords
Ovarian cancer, ID8 cells, Wound healing, Cisplatin, Mouse, Chemoresistance
Journal
Journal of Ovarian Research
Volume 11, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-07-04
DOI
10.1186/s13048-018-0428-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
- (2018) Willemien J. van Driel et al. NEW ENGLAND JOURNAL OF MEDICINE
- CRISPR/Cas9-Mediated Trp53 and Brca2 Knockout to Generate Improved Murine Models of Ovarian High-Grade Serous Carcinoma
- (2016) J. Walton et al. CANCER RESEARCH
- Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology/Gynecologic Oncology Group study
- (2015) K. S. Tewari et al. ANNALS OF ONCOLOGY
- The dark side of ID8-Luc2: pitfalls for luciferase tagged murine models for ovarian cancer
- (2015) Thaïs Baert et al. Journal for ImmunoTherapy of Cancer
- A statistical analysis of murine incisional and excisional acute wound models
- (2014) David M. Ansell et al. WOUND REPAIR AND REGENERATION
- Surgery, wound healing, and metastasis: Recent insights and clinical implications
- (2013) Wim Ceelen et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma — Analysis of patient data in the prospective OVCAD study
- (2013) G. Hofstetter et al. GYNECOLOGIC ONCOLOGY
- Latest research and treatment of advanced-stage epithelial ovarian cancer
- (2013) Robert L. Coleman et al. Nature Reviews Clinical Oncology
- Ten-Year Relative Survival for Epithelial Ovarian Cancer
- (2012) Lauren A. Baldwin et al. OBSTETRICS AND GYNECOLOGY
- Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer
- (2011) James J. Biagi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A hyperactive piggyBac transposase for mammalian applications
- (2011) K. Yusa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo
- (2010) Pierfrancesco Tassone et al. CANCER BIOLOGY & THERAPY
- Surgery Triggers Outgrowth of Latent Distant Disease in Breast Cancer: An Inconvenient Truth?
- (2010) Michael Retsky et al. Cancers
- Increased mRNA expression of epidermal growth factor receptor, human epidermal receptor, and survivin in human gastric cancer after the surgical stress of laparotomy versus carbon dioxide pneumoperitoneum in a murine model
- (2009) Anwar Tawfik Amin et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- BRCA1/2 genetic background-based therapeutic tailoring of human ovarian cancer: hope or reality?
- (2009) Pierosandro Tagliaferri et al. Journal of Ovarian Research
- The effects of surgery on tumor growth: a century of investigations
- (2008) R. Demicheli et al. ANNALS OF ONCOLOGY
- Epithelial–stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer
- (2007) James Greenaway et al. GYNECOLOGIC ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now